Grupo Español Multidisciplinar De Melanoma

This study is testing a two-step treatment for people with advanced melanoma that has spread to the brain and is causing symptoms. First, patients take two pills (encorafenib and binimetinib) for about two months. Then, they receive two intravenous drugs (cemiplimab and fianlimab…

This study is testing whether combining two drugs, enfortumab vedotin and pembrolizumab, can help control advanced melanoma that has continued to grow despite standard immunotherapy. It will enroll about 60 adults whose cancer has worsened after prior treatment. The main goal is …

This study is testing a drug called tebentafusp in patients with a rare eye cancer (uveal melanoma) that has spread only to the liver. The goal is to see if giving the drug for six months before surgery can completely eliminate the cancer in the liver and help keep it from coming…